David Ebrahimzadeh and Corniche Capital formalize a differentiated capital allocation model combining industrial real estate acquisition, build-to-suit development, and strategic investments in ...
New York, USAKeystone announced an update to its Compounding Co-Creator Strategic Partner Program with the introduction ...
In biotechnology, timing is everything. Whether advancing a novel therapy or scaling a platform, companies often reach a pivotal point: go public or sell. Increasingly, biotech executives are choosing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results